Profound MedicalPROF +1.43%73 Gross Margin % is 71.80% as of Mar. 2026, which is 51% above its 10-year median of 47.56. GuruFocus rates PROF with a GF Score™ of 73/100 and a GF Value™ of $14.28 (Possible Value Trap). The stock has 1 warning sign investors should review. Among 805 Medical Devices & Instruments companies, Profound Medical ranks better than 82.11% on this metric.
The historical rank and industry rank for Profound Medical's Gross Margin % or its related term are showing as below:
PROF'
s Gross Margin % Range Over the Past 10 Years
Min: 31.66 Med: 47.56 Max: 71.08
Current: 71.08
During the past 12 years, the highestGross Margin % of Profound Medical was 71.08%. The lowest was 31.66%. And the median was 47.56%.
PROF's Gross Margin % is ranked better than 82.11% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 52.03
vs PROF: 71.08
Profound Medical had a gross margin of 71.80% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Profound Medical was 10.70% per year.
Profound Medical (NAS:PROF) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Profound Medical had a gross margin of 71.80% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Profound Medical Gross Margin % Related Terms
Profound Medical Gross Margin % Historical Data
* Premium members only.
The historical data trend for Profound Medical's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Profound Medical's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Profound Medical Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Profound Medical's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Profound Medical's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Profound Medical (PROF) has a Gross Margin % of 71.80% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Profound Medical and its competitors. This is 51% above median its historical median of 47.56. Over the past decade, Profound Medical's Gross Margin % has ranged from 31.66 to 71.08. According to the industry distribution chart, Profound Medical ranks #144 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 17.9%.
Is Profound Medical's Gross Margin % too high?
Profound Medical's current Gross Margin % of 71.80% is 51% above median its 10-year median of 47.56. Over the past 10 years, this metric has ranged from a low of 31.66 to a high of 71.08. The Medical Devices & Instruments industry median Gross Margin % is 52.03. Profound Medical's value of 71.80% is 38% above this industry median. Based on the distribution chart, Profound Medical ranks #144 out of 805 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Profound Medical has a GF Score™ of 73/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Profound Medical's Gross Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Profound Medical ranks #144 out of 805 companies for Gross Margin %. This places Profound Medical in the top 18% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 52.03. Profound Medical's value of 71.80% is 38% above this benchmark. Historically, Profound Medical's own Gross Margin % has ranged from 31.66 to 71.08 over the past decade. While the company's 10-year median is 47.56 vs. the industry median of 52.03, Profound Medical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.03, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Profound Medical's current Gross Margin % of 71.80% is 38% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Profound Medical and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Profound Medical's current Gross Margin % is 71.80%, which is 51% above median its own 10-year median of 47.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Profound Medical stock overvalued right now?
Based on GuruFocus' analysis, Profound Medical (PROF) is currently considered Possible Value Trap. The stock's GF Value™ is $14.28, compared to a current price of $7.44 — trading 47.9% below its estimated fair value. The current Gross Margin % is 71.80%, which is 51% above median its 10-year median of 47.56 and 38% above the Medical Devices & Instruments industry median of 52.03. Profound Medical's overall GF Score™ is 73/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Profound Medical (PROF), the current Gross Margin % is 71.80% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Profound Medical (PROF) Overvalued in 2026?
Based on GuruFocus' analysis, Profound Medical stock appears to be undervalued.
The current stock price of $7.44 is trading 47.9% below its estimated GF Value™ of $14.28.
GuruFocus considers Profound Medical to be Possible Value Trap.
Key valuation signals for PROF:
Gross Margin %: 71.80% (51% above median its 10-year median of 47.56)
GF Value™: $14.28 vs. price of $7.44 (47.9% below fair value)
Industry Position: 38% above the Medical Devices & Instruments median (#144 of 805)
No single metric tells the full story. See the PROF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of AI-powered, MRI-guided, incision-free therapies for the ablation of diseased tissue. The company's flagship product, the TULSA-PRO system, combines real-time MRI, robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. Its platform technologies combine imaging, robotic control, and ultrasound-based thermal ablation for the treatment of prostate conditions. The company generates revenue through the sale of capital equipment and recurring sales of single-use devices and related services used in patient treatments.
73GF Score
Get the complete analysis for PROF
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PROF has been successfully added to your 
